Cargando…

Patient outcomes after electrical injury – a retrospective study

INTRODUCTION: People exposed to electrical injuries are often admitted to hospital for observation. Current evidence suggests that patients who have a normal ECG on admission after a low-voltage injury, with no loss of consciousness or initial cardiac arrest may be discharged home after a short obse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Jamal, Stenkula, Charlotte, Omar, Sherwan, Ghanima, Josef, Bremtun, Fredrik Førsund, Bergan, Jonas, Raouf, Nezar, Ghanima, Waleed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344194/ https://www.ncbi.nlm.nih.gov/pubmed/34362435 http://dx.doi.org/10.1186/s13049-021-00920-3

Ejemplares similares

Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases
por: Overstad, Siri, et al.
Publicado: (2020)

Fatigue after initiating rivaroxaban for venous thromboembolism
por: Karlsvik, Tina Margrethe, et al.
Publicado: (2020)

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
por: Tsykunova, Galina, et al.
Publicado: (2022)

Quality of life after COVID-19 without hospitalisation: Good overall, but reduced in some dimensions
por: Garratt, Andrew M., et al.
Publicado: (2021)

P1604: IMPACT OF THROMBOPOIETIN LEVEL ON PLATELET RESPONSE IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA TREATED WITH RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR
por: Kuter, David, et al.
Publicado: (2023)

Does the clot burden as assessed by the Mean Bilateral Proximal Extension of the Clot score reflect mortality and adverse outcome after pulmonary embolism?
por: Gleditsch, Jostein, et al.
Publicado: (2023)

Risk of cardiovascular events and pulmonary hypertension following splenectomy — a Danish population-based cohort study from 1996–2012
por: Rørholt, Marianne, et al.
Publicado: (2017)

Prevalence and Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A Population-Based Study
por: Stavem, Knut, et al.
Publicado: (2021)

Prevalence and Risk Factors for Post-Traumatic Stress in Hospitalized and Non-Hospitalized COVID-19 Patients
por: Einvik, Gunnar, et al.
Publicado: (2021)

Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study
por: Stavem, Knut, et al.
Publicado: (2021)

Cognitive function in non-hospitalized patients 8–13 months after acute COVID-19 infection: A cohort study in Norway
por: Stavem, Knut, et al.
Publicado: (2022)

The venous thrombosis registry in Østfold Hospital (TROLL registry) ‐ design and cohort description
por: Jørgensen, Camilla Tøvik, et al.
Publicado: (2022)

Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis
por: Tholin, Birgitte, et al.
Publicado: (2022)

Thrombopoietin receptor agonists: ten years later
por: Ghanima, Waleed, et al.
Publicado: (2019)

The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients—a single-arm prospective trial
por: Myklebust-Hansen, Hans Joakim, et al.
Publicado: (2023)

New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2018)

Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
por: Rutherford, Ole-Christian W, et al.
Publicado: (2020)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
por: Tholin, Birgitte, et al.
Publicado: (2021)

How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh)
por: Chakrabarti, Prantar, et al.
Publicado: (2022)

Anxiety and depression among vaccinated anesthesia and intensive care doctors during COVID-19 pandemic in United Arab Emirates: a cross-sectional study
por: Rizk, Dalia Nagui, et al.
Publicado: (2022)

Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms – Impact Of Comorbidity
por: Frederiksen, Henrik, et al.
Publicado: (2019)

Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism
por: Gleditsch, Jostein, et al.
Publicado: (2021)

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
por: Halvorsen, Sigrun, et al.
Publicado: (2017)

Health-related quality of life after deep vein thrombosis
por: Utne, Kristin Kornelia, et al.
Publicado: (2016)

Health-related quality of life after pulmonary embolism: a cross-sectional study
por: Tavoly, Mazdak, et al.
Publicado: (2016)

Age-Related Macular Degeneration in Primary Osteoarthritis Egyptian Patients
por: Mahgoub, Marwa Yahia, et al.
Publicado: (2020)

A qualitative study of patient experiences of decentralized acute healthcare services
por: Linqvist Leonardsen, Ann-Chatrin, et al.
Publicado: (2016)

Health‐related quality‐of‐life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology
por: Asady, Elia, et al.
Publicado: (2021)

PB2608: THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA (ITP) IN NORWAY IN THE REAL LIFE – ANALYSIS OF THE NOR-ITP REGISTRY
por: Ilicheva, Ekaterina, et al.
Publicado: (2023)

Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence
por: Kissani, Najib, et al.
Publicado: (2020)

Evaluation of a new point-of-care diagnostic test measuring inflammation in emergency settings
por: Charansonney, Olivier L., et al.
Publicado: (2023)

P1638: EARLY USE OF ELTROMBOPAG IN ADULT PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE CORTICOSTEROID THERAPY – AN AD HOC ANALYSIS OF THE TAPER TRIAL RESULTS
por: Ghanima, W., et al.
Publicado: (2022)

Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
por: Terrell, Deirdra R., et al.
Publicado: (2020)

Psychological impact of first admission with cardiovascular disease in a tertiary hospital in Oman
por: Al-Maskari, Ahmed, et al.
Publicado: (2023)

Neurogenic bladder in spinal cord injury patients
por: Taweel, Waleed Al, et al.
Publicado: (2015)

PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT
por: Zaja, Francesco, et al.
Publicado: (2023)

PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
por: Cooper, Nichola, et al.
Publicado: (2023)

Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
por: Kuter, David J., et al.
Publicado: (2023)

Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim
por: Christiansen, Christian Fynbo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qtk91il9rj5pkccm98fr60qdaa